TwinBeech Capital’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-370,804
Closed -$25M 663
2025
Q3
$25M Buy
+370,804
New +$29.3M 0.99% 24
2025
Q2
Sell
-938,186
Closed -$64.1M 730
2025
Q1
$64.1M Buy
938,186
+409,035
+77% +$33.4M 1.16% 11
2024
Q4
$41.2M Buy
529,151
+466,312
+742% +$34.5M 0.7% 46
2024
Q3
$4.21M Sell
62,839
-266,843
-81% -$21.9M 0.08% 284
2024
Q2
$37.4M Buy
+329,682
New +$41.7M 0.74% 37
2023
Q4
Sell
-247,715
Closed -$23.1M 711
2023
Q3
$23.1M Buy
+247,715
New +$27.9M 0.44% 58
2023
Q2
Sell
-289,965
Closed -$33.7M 667
2023
Q1
$33.7M Buy
289,965
+55,558
+24% +$6.22M 0.68% 31
2022
Q4
$26.5M Buy
+234,407
New +$25.7M 0.5% 50
2022
Q1
Sell
-161,788
Closed -$21.7M 559
2021
Q4
$21.7M Buy
+161,788
New +$23.2M 1.24% 4
2021
Q2
Sell
-4,200
Closed -$377K 485
2021
Q1
$377K Buy
+4,200
New +$394K 0.06% 337
2020
Q1
Sell
-69,244
Closed -$3.79M 335
2019
Q4
$3.79M Buy
+69,244
New +$3.28M 1.1% 7

Other funds holding DXCM

TwinBeech Capital's DXCM Position: Q4 2025 in Review

TwinBeech Capital sold out of DexCom (DXCM) in Q4 2025, closing a stake of 370,804 shares — an estimated $25M sold.

TwinBeech Capital first reported a position in DXCM in Q4 2019 and held it in 11 quarters. The position peaked at $64.1M in Q1 2025. 920 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • TwinBeech Capital reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
  • TwinBeech Capital sold 370,804 DexCom shares in Q4 2025, an estimated $25M.
  • TwinBeech Capital first reported a position in DexCom in Q4 2019 and held it in 11 quarters.
  • TwinBeech Capital's DexCom position peaked at $64.1M in Q1 2025.
  • 920 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on TwinBeech Capital's 13F filing for Q4 2025, filed 17 Feb 2026.